Personalized Cancer Care


Event Details


What have we achieved since 2012 in risk prediction, early diagnosis, progression, and therapy?
This Symposium is part of an annual series that Prof. Enrico Mihich has been organizing in collaboration with Hans-Peter Huber and Kurt S. Zänker at the Fritz Bender Foundation, Munich, Germany and a host institution.

In 2012 this symposium took place in Oslo, Norway with the Institute for Cancer Research at the Norwegian Radium Hospital Oslo University Hospital and the Radium Hospital Foundation as hosts. It was decided at that meeting that a second symposium with the same program and speakers should take place 3-4 years later with the focus on what have we achieved since 2012. Hence the follow-up meeting will take place in Oslo in May 2016.

Oslo Cancer Cluster will have a stand and encourages members to support this event by a stand also.

Contact person: Anne-Lise Børresen-Dale

 

 

 

Topics and speakers

Opening keynote

  • Leroy Hood, Institute for Systems Biology, Seattle, USA

Genetic profiling of patients, prediction of risk and therapy response

  • Bruce Ponder, Cancer Research UK, Cambridge Research Inst, UK
  • Paul Pharoah, Strangeways Research Lab, Cambridge, UK

Molecular profiling of tumors and metastases

  • Elaine Mardis, The Genome Inst, Washington Uni, MO, USA
  • Zoltan Szallasi, Technical University of Denmark
  • Carlos Caldas, Cancer Research UK, Cambridge Research Inst, UK
  • Peter van Loo, Crick Center, London, UK
  • Charles M. Perou , UNC – Chapel Hill, NC, USA

Tumor-host microenvironment interaction and metabolism

  • Arnold Levine, Princeton University, USA
  • Larry Norton, Memorial Sloan-Kettering Cancer Center, NY, USA
  • Mina Bissell, Lawrence Berkley National Laboratory, CA, USA
  • Morag Park, McGill University, Montreal, Canada

Targeted therapy

  • Gordon Mills, MD Andersson Cancer Center, TX, USA
  • Rene Bernards, The Netherlands Cancer Institute, The Netherlands
  • Joe Gray, Oregon Health & Science University, OR, USA
  • Alberto Bardelli, University of Torino, Italy
  • Soldano Ferrone, Mass General Hosp, Harvard, MA, USA

Translation

  • Olli Kallioniemi, FIMM, Helsinki, Finland
  • Laura van’t Veer, University of California, CA, USA
  • Per Eystein Lønning, University of Bergen, Norway
  • Anne-Lise Børresen-Dale, Oslo Univ Hospital, Norway

Impact of social and ethical issues on personalized medicine

  • David Livingstone, Dana-Farber Cancer Inst, MA, USA
  • Serena Nik-Zainal, Sanger Center, Cambridge, UK

Opening and closing remarks

  • Enrico Mihich
  • Hans-P. Huber
  • A.-L. Børresen-Dale
  • Kurt S. Zänker

 

Abstract submission deadline March 14
Registration deadline April 1.

Visit the symposium web page for more info.

 

 

 

Print This Post